What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Zyclara (Imiquimod)

Sezzle
Brand

Zyclara (Imiquimod)

Prescription Required

Strength
Qty
3.75%

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using Sezzle

We don't have this generic product yet!

Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.

  • Product Details

    Description

    Your doctor may prescribe Zyclara if you have specific skin conditions such as actinic keratosis (AK) on the face or scalp. AK manifests as rough, scaly patches resulting from prolonged sun exposure and poses a risk of progressing to skin cancer.

    Imiquimod modifies the immune response. It stimulates both the innate and adaptive immune systems and induces the release of cytokines like interferon-alpha. These mediators bolster the immune response, aiding in the identification and elimination of abnormal cells, including those characteristic of actinic keratosis.

    Fact Table

    Formula

    C14H16N4

    License

    US FDA

    Bioavailability

    ~0.9% (topical)

    Legal status

    Prescription only (?)

    Chemical Name

    1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine

    Elimination half-life

    ~30 hours

    Dosage (Strength)

    2.5%, 3.75%, 5% cream

    Pregnancy

    Use with caution

    Brands

    Zyclara, Aldara

    Protein binding

    ~93%

    PubChem CID

    57469

    MedlinePlus

    a698010

    ChEBI

    CHEBI:37980

    ATC code

    D06BB10

    DrugBank

    DB00724

    KEGG

    D08067

    Routes of administration

    Topical

    Directions

    Zyclara is applied topically once daily to the affected area.

    To treat actinic keratosis, Zyclara is typically applied for two weeks, followed by a two-week break, and then another two-week treatment cycle if necessary.

    Wash and dry the area gently and thoroughly before applying Zyclara.

    Ingredients

    The active ingredient in Zyclara is imiquimod.

    Interactions

    There are no significant drug-drug interactions between Zyclara and other medications

    Cautions

    Discontinue Zyclara and consult a healthcare provider if severe systemic reactions like allergic hypersensitivity occur. Symptoms include trouble breathing, hives, and swelling of the airway.

    You and your doctor should monitor for local skin reactions such as redness, swelling, and erosion, which may necessitate treatment interruption.

    Tell your doctor if you have a history of problems with your immune system because Zyclara can worsen these conditions.

    Avoid sun exposure and tanning beds during Zyclara use to reduce the risk of increased sunburn susceptibility. Wear protective clothing and apply sunscreen when outdoors.

    Side Effects

    Adverse reactions to Zyclara include:

    • Application site reaction
    • Burning sensation
    • Cardiac dysrhythmia
    • Cerebrovascular accident
    • Edematous skin
    • Erythema
    • Erythema multiforme
    • Erythroderma
    • Female genital edema
    • Headache
    • Heart failure
    • Immune thrombocytopenia
    • Influenza-like illness
    • Myocardial infarction
    • Peeling of skin
    • Pruritus
    • Scab of skin
    • Skin discharge
    • Skin ulcer
    • Syncope
    • Upper respiratory infection

    References

    Zyclara [package insert]. Bristol, TN: Graceway; March 2010.



    IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

    Product Code : 11615

  • Product Reviews

Processing..

Please wait while the page is loading. Do not hit refresh or the browser back button to avoid any loss of information.

If you have any questions or concerns, please contact our Customer Service team via the chat option on our website or calling us toll free at: 1-800-891-0844